Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2443
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMATIAS, Andreza C.
dc.contributor.authorMANIERI, Tania M.
dc.contributor.authorCIPRIANO, Samantha S.
dc.contributor.authorCARIONI, Vivian M. O.
dc.contributor.authorNOMURA, Cassiana S.
dc.contributor.authorMACHADO, Camila M. L.
dc.contributor.authorCERCHIARO, Giselle
dc.date.accessioned2013-09-23T16:55:51Z
dc.date.available2013-09-23T16:55:51Z
dc.date.issued2013
dc.identifier.citationTOXICOLOGY IN VITRO, v.27, n.1, p.349-357, 2013
dc.identifier.issn0887-2333
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2443
dc.description.abstractDithiocarbamates are nitrogen- and sulfur-containing compounds commonly used in pharmacology, medicine and agriculture. The molecular effects of dithiocarbamates on neuronal cell systems are not fully understood, especially in terms of their ability to accumulate copper ions inside the cell. In this work, the molecular effects of N,N-diethyldithiocarbamate (DEDTC) were studied in human SH-SY5Y neuroblastoma cells to determine the role of copper in the DEDTC toxicity and the pathway trigged in cell by the complex Cu-DEDTC. From concentration-dependent studies, we found that 5 mu M of this compound induced a drastic decrease in viable cells with a concomitant accumulation in intracellular copper resulted from complexation with DEDTC, measured by atomic absorption spectroscopy. The mechanism of DEDTC-induced apoptosis in neuronal model cells is thought to occur through the death receptor signaling triggered by DEDTC-copper complex in low concentration that is associated with the activation of caspase 8. Our results indicated that the mechanism of cell death involves cytochrome c release forming the apoptosome together with Apaf-1 and caspase 9, converting the caspase 9 into its active form, allowing it to activate caspase 3 as observed by immunofluorescence. This pathway is induced by the cytotoxic effects that occur when DEDTC forms a complex with the copper ions present in the culture medium and transports them into the cell, suggesting that the DEDTC by itself was not able to cause cell death and the major effect is from its copper-complex in neuroblastoma cells. The present study suggests a role for the influence of copper by low concentrations of DEDTC in the extracellular media, the absorption and accumulation of copper in the cell and apoptotic events, induced by the cytotoxic effects that occur when DEDTC forms a complex with the copper ions.
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
dc.description.sponsorshipNational Council for Scientific and Technological Development (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relation.ispartofToxicology in Vitro
dc.rightsrestrictedAccess
dc.subjectDiethyldithiocarbamate
dc.subjectCopper uptake
dc.subjectCopper toxicity
dc.subjectApoptosis
dc.subjectDEDTC
dc.subjectCytochrome c release
dc.subjectNeuroblastoma
dc.subjectSH-SY5Y
dc.subject.otheroxidative stress
dc.subject.otherpyrrolidine dithiocarbamate
dc.subject.otherlipid oxidation
dc.subject.othermyelin injury
dc.subject.othern,n-diethyldithiocarbamate
dc.subject.otheraccumulation
dc.subject.otherinvolvement
dc.subject.othercomplexes
dc.subject.otherdamage
dc.subject.otherdeath
dc.titleDiethyldithiocarbamate induces apoptosis in neuroblastoma cells by raising the intracellular copper level, triggering cytochrome c release and caspase activation
dc.typearticle
dc.rights.holderCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.identifier.doi10.1016/j.tiv.2012.08.017
dc.identifier.pmid22951949
dc.subject.wosToxicology
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
hcfmusp.author.externalMATIAS, Andreza C.:Fed Univ ABC UFABC, Ctr Nat Sci & Humanities, BR-09210170 Santo Andre, SP, Brazil
hcfmusp.author.externalMANIERI, Tania M.:Fed Univ ABC UFABC, Ctr Nat Sci & Humanities, BR-09210170 Santo Andre, SP, Brazil
hcfmusp.author.externalCIPRIANO, Samantha S.:Fed Univ ABC UFABC, Ctr Nat Sci & Humanities, BR-09210170 Santo Andre, SP, Brazil
hcfmusp.author.externalCARIONI, Vivian M. O.:Fed Univ ABC UFABC, Ctr Nat Sci & Humanities, BR-09210170 Santo Andre, SP, Brazil
hcfmusp.author.externalNOMURA, Cassiana S.:Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, Brazil
hcfmusp.author.externalCERCHIARO, Giselle:Fed Univ ABC UFABC, Ctr Nat Sci & Humanities, BR-09210170 Santo Andre, SP, Brazil
hcfmusp.description.beginpage349
hcfmusp.description.endpage357
hcfmusp.description.issue1
hcfmusp.description.volume27
hcfmusp.origemWOS
hcfmusp.origem.id2-s2.0-85027924086
hcfmusp.origem.idWOS:000314371600041
hcfmusp.publisher.cityOXFORD
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAkiyama N, 2006, TOXICOL APPL PHARM, V215, P218, DOI 10.1016/j.taap.2006.02.013
hcfmusp.relation.referenceALLAIN P, 1993, RES COMMUN CHEM PATH, V80, P105
hcfmusp.relation.referenceAravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3
hcfmusp.relation.referenceArciello M, 2005, BIOCHEM BIOPH RES CO, V327, P454, DOI 10.1016/j.bbrc.2004.12.022
hcfmusp.relation.referenceBudihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
hcfmusp.relation.referenceCen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z
hcfmusp.relation.referenceChen J, 2008, CHEM-BIOL INTERACT, V171, P26, DOI 10.1016/j.cbi.2007.09.004
hcfmusp.relation.referenceChen SH, 2008, EUR J PHARMACOL, V594, P9, DOI 10.1016/j.ejphar.2008.07.024
hcfmusp.relation.referenceCulmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149
hcfmusp.relation.referenceDaniel KG, 2005, BREAST CANCER RES, V7, pR897, DOI 10.1186/bcr1322
hcfmusp.relation.referenceDing XQ, 2011, J NUTR BIOCHEM, V22, P301, DOI 10.1016/j.jnutbio.2010.06.010
hcfmusp.relation.referencedo Lago LCC, 2011, J INORG BIOCHEM, V105, P189, DOI [10.1016/j.jinorgbio.2010.10.017, 10.1016/j.jinorgbio.2010.10.0172]
hcfmusp.relation.referenceENEANYA DI, 1981, ANNU REV PHARMACOL, V21, P575, DOI 10.1146/annurev.pa.21.040181.003043
hcfmusp.relation.referenceFilomeni G, 2007, J BIOL CHEM, V282, P12010, DOI 10.1074/jbc.M610927200
hcfmusp.relation.referenceGabbianelli R, 1999, J NEUROCHEM, V73, P1175, DOI 10.1046/j.1471-4159.1999.0731175.x
hcfmusp.relation.referenceGrosicka-Maciag E, 2012, PESTIC BIOCHEM PHYS, V102, P95, DOI 10.1016/j.pestbp.2011.11.003
hcfmusp.relation.referenceHacker HG, 2011, PHARMACOL THERAPEUT, V132, P180, DOI 10.1016/j.pharmthera.2011.07.003
hcfmusp.relation.referenceHULANICK.A, 1967, TALANTA, V14, P1371, DOI 10.1016/0039-9140(67)80159-0
hcfmusp.relation.referenceKimoto-Kinoshita S, 2004, MOL CELL BIOCHEM, V265, P123, DOI 10.1023/B:MCBI.0000044366.32073.2d
hcfmusp.relation.referenceLAKOMAA EL, 1982, TOXICOL APPL PHARM, V65, P286, DOI 10.1016/0041-008X(82)90011-4
hcfmusp.relation.referenceLOWRY OH, 1951, J BIOL CHEM, V193, P265
hcfmusp.relation.referenceMarengo B, 2005, CANCER LETT, V228, P111, DOI 10.1016/j.canlet.2005.01.046
hcfmusp.relation.referenceMeulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337
hcfmusp.relation.referenceMorrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103
hcfmusp.relation.referenceMOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
hcfmusp.relation.referenceNOBEL CSI, 1995, J BIOL CHEM, V270, P26202
hcfmusp.relation.referenceSafety I.P.o.C., 1988, DITH PEST ETH PROP G
hcfmusp.relation.referenceSUNDERMAN FW, 1979, ANN CLIN LAB SCI, V9, P1
hcfmusp.relation.referenceTonkin EG, 2004, TOXICOL SCI, V81, P160, DOI 10.1093/toxsci/kfh190
hcfmusp.relation.referenceUtrera J, 2011, EUR J NEUROSCI, V34, P2007, DOI 10.1111/j.1460-9568.2011.07928.x
hcfmusp.relation.referenceValentine HL, 2009, CHEM RES TOXICOL, V22, P218, DOI 10.1021/tx8003714
hcfmusp.relation.referenceViola-Rhenals M, 2007, BIOCHEM PHARMACOL, V74, P841, DOI 10.1016/j.bcp.2007.06.048
hcfmusp.relation.referenceViola-Rhenals M, 2006, BIOCHEM PHARMACOL, V71, P722, DOI 10.1016/j.bcp.2005.11.028
hcfmusp.relation.referenceViquez OM, 2008, TOXICOL APPL PHARM, V229, P77, DOI 10.1016/j.taap.2008.01.005
hcfmusp.relation.referenceWarshawsky A, 2001, LANGMUIR, V17, P5621, DOI 10.1021/la010299e
hcfmusp.relation.referenceWu CC, 2012, TOXICOL LETT, V208, P275, DOI 10.1016/j.toxlet.2011.10.022
dc.description.indexMEDLINE
hcfmusp.remissive.sponsorshipCNPq
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.citation.scopus35-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - LIM/43
LIM/43 - Laboratório de Medicina Nuclear

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_MACHADO_Diethyldithiocarbamate_induces_apoptosis_in_neuroblastoma_cells_by_raising_2013.PDF
  Restricted Access
publishedVersion (English)1.26 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.